Tibet Rhodiola Pharmaceutical Holding Co
600211
Company Profile
Business description
Tibet Rhodiola Pharmaceutical Holding Co is a pharmaceutical company engaged in the production and sales of capsules, biological agents, granules, and coatings. The company's products cover biopharmaceuticals, Tibetan medicine, traditional Chinese medicine, and chemical drugs, involving fields such as cardiovascular and cerebrovascular diseases, hepatobiliary diseases, orthopedic pain relief, rheumatism, and cold medicines.
Contact
No. 3 Guangzhou Road
Area A, Lhasa Economic and Technological Development Zone
Tibet Autonomous Region
Lhasa850000
CHNT: +86 2886653915
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
671
Stocks News & Analysis
stocks
Disney earnings: Experiences and streaming again drive excellent results
We believe Disney’s irreplaceable characters will continue to drive a healthy experiences business, which we estimate is worth nearly as much as the market values the whole firm.
stocks
ASX utility share downgraded as electricity prices fall
Falling electricity prices weigh on earnings outlook for utility provider.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,445.10 | 33.80 | 0.36% |
| CAC 40 | 8,721.93 | 22.22 | 0.26% |
| DAX 40 | 26,322.53 | 182.40 | 0.70% |
| Dow JONES (US) | 53,959.32 | 74.22 | 0.14% |
| FTSE 100 | 10,916.78 | 48.89 | 0.45% |
| HKSE | 25,668.03 | 137.75 | 0.54% |
| NASDAQ | 26,529.02 | 180.66 | 0.69% |
| Nikkei 225 | 65,606.71 | 76.55 | -0.12% |
| NZX 50 Index | 13,824.13 | 133.93 | -0.96% |
| S&P 500 | 7,729.19 | 19.23 | 0.25% |
| S&P/ASX 200 | 9,263.60 | 34.80 | 0.38% |
| SSE Composite Index | 3,940.04 | 39.68 | 1.02% |